These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5351123)

  • 1. [The capillary barrier for dopa in brain and different organs].
    Constantinidis J; De La Torre JC; Tissot R; Geissbuhler F
    Psychopharmacologia; 1969; 15(2):75-87. PubMed ID: 5351123
    [No Abstract]   [Full Text] [Related]  

  • 2. A rapid fluorescence microscopic method for the study of the capillary DOPA-dopamine barrier.
    Jancsó G
    J Neurochem; 1975 Mar; 24(3):579-80. PubMed ID: 1113128
    [No Abstract]   [Full Text] [Related]  

  • 3. THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES.
    BERTLER A; FALCK B; ROSENGREN E
    Acta Pharmacol Toxicol (Copenh); 1963; 20():317-21. PubMed ID: 14162814
    [No Abstract]   [Full Text] [Related]  

  • 4. Decarboxylase activity of the brain capillary walls and parenchyma in the rat, cat and monkey.
    Langelier P; Parent A; Poirier LJ
    Brain Res; 1972 Oct; 45(2):622-9. PubMed ID: 4628637
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine formation in brain capillaries--an enzymic blood-brain barrier mechanism.
    Owman C; Rosengren E
    J Neurochem; 1967 May; 14(5):547-50. PubMed ID: 6025622
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the enzymatic blood-brain barrier: quantitative measurements of DOPA decarboxylase in the wall of microvessels as related to the parenchyma in various CNS regions.
    Hardebo JE; Falck B; Owman C; Rosengren E
    Acta Physiol Scand; 1979 Apr; 105(4):453-60. PubMed ID: 452922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nickel chloride on the permeability of the blood-brain barrier.
    Várkonyi T; Joó F
    Experientia; 1968 May; 24(5):452-3. PubMed ID: 4300029
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interpretation of the mechanism of the monoamine barrier in the cerebral capillaries].
    Donáth T; Tauber F
    Morphol Igazsagugyi Orv Sz; 1974 Oct; 14(4):273-9. PubMed ID: 4427600
    [No Abstract]   [Full Text] [Related]  

  • 9. DOPA decarboxylase.
    Gjedde A
    Mov Disord; 1996 Jul; 11(4):462-3. PubMed ID: 8813239
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the therapy of parkinsonism with L-dopa: inhibition of dopa decarboxylase].
    Nurzia A
    Clin Ter; 1975 Feb; 72(3):289-95. PubMed ID: 1132216
    [No Abstract]   [Full Text] [Related]  

  • 11. [Some functional consequences of the blood-brain barrier for catecholamines and their precursors].
    Tissot R; Gaillard JM; Constantinidis J; Geissbühler P
    Acta Physiol Pol; 1973; 24(1):61-70. PubMed ID: 4716349
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of renal extracts on capillary permeability in the rat brain. An electron microscope study.
    Shibasaki H; Yamamoto T; Hattori N; Omae T
    Arch Histol Jpn; 1969 Aug; 30(5):437-47. PubMed ID: 5388103
    [No Abstract]   [Full Text] [Related]  

  • 13. Dementia dialytica.
    Vaisrub S
    JAMA; 1973 Oct; 226(2):190. PubMed ID: 4740913
    [No Abstract]   [Full Text] [Related]  

  • 14. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface.
    Hardebo JE; Owman C
    Ann Neurol; 1980 Jul; 8(1):1-31. PubMed ID: 6105837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of DOPA decarboxylase activity in brain of living rat.
    Cumming P; Kuwabara H; Ase A; Gjedde A
    J Neurochem; 1995 Sep; 65(3):1381-90. PubMed ID: 7643116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].
    Constantinidis J; Bartholini G; Geissbühler F; Tissot R
    Experientia; 1970 Apr; 26(4):381-3. PubMed ID: 5439606
    [No Abstract]   [Full Text] [Related]  

  • 17. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.
    Constantinidis J; Gaillard JM; Geissbuhler F; Tissot R
    Br J Pharmacol; 1971 Sep; 43(1):32-8. PubMed ID: 5136462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetic behaviour of [3H]DOPA in living rat brain investigated by compartmental modelling of static autoradiograms.
    Deep P; Kuwabara H; Gjedde A; Cumming P
    J Neurosci Methods; 1997 Dec; 78(1-2):157-68. PubMed ID: 9497012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of octanoate on blood-brain barrier permeability using L-dopa as a marker.
    Trauner DA; de la Torre JC
    Pediatr Neurol; 1985; 1(4):223-5. PubMed ID: 3880408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does L-dopa work in parkinsonism?
    Sandler M
    Lancet; 1971 Apr; 1(7703):784. PubMed ID: 4101278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.